A novel flavonoid, 6-C-β-d-glucopyranosyl-(2S,3S)-(+)-3′, 4′,5,7-tetrahydroxyflavanone, isolated from Ulmus wallichiana Planchon mitigates ovariectomy-induced osteoporosis in rats

Menopause

Volumn 17, Issue 3, 2010, Pages 577-586

  Sharan, Kunal ^a   Swarnkar, Gaurav ^a   Siddiqui, Jawed A ^a   Kumar, Avinash ^a   Rawat, Preeti ^a   Kumar, Manmeet ^a   Nagar, Geet K ^a   Manickavasagam, Lakshmi ^a   Singh, Sheelendra P ^a   Mishra, Geetanjali ^a   Wahajuddin, ^a   Jain, Girish K ^a   Maurya, Rakesh ^a   Chattopadhyay, Naibedya ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Antiresorptive; Bioavailability; Bone strength; Estrogenicity; Phytoestrogen

Indexed keywords

6 C BETA DEXTRO GLUCOPYRANOSYL 3',4',5,7 TETRAHYDROXYFLAVANONE; ESTRADIOL; FLAVANOID; OSTEOCALCIN; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE STRENGTH; BONE TURNOVER; CONTROLLED STUDY; CORTICAL BONE; DOSE RESPONSE; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PURIFICATION; DRUG STRUCTURE; ELM; FEMALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN BLOOD LEVEL; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION; TRABECULAR BONE; TREATMENT DURATION; ULMUS WALLICHIANA;

ANIMALS; BONE DENSITY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLAVONOIDS; GLYCOSIDES; HALF-LIFE; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; OSTEOPOROSIS; OVARIECTOMY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; ULMUS;

EID: 77952291901     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181d2ce7f     Document Type: Article

References (32)

1. Li B, Yu S. Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation. Biol Pharm Bull 2003;26:780-786.
2. Anderson JJ, Ambrose WW, Garner SC. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc Soc Exp Biol Med 1998;217:345-350.
3. Somjen D, Katzburg S, Kohen F, Gayer B, Livne E. Daidzein but not other phytoestrogens preserves bone architecture in ovariectomized female rats in vivo. J Cell Biochem 2008;103:1826-1832.
4. Fonseca D, Ward WE. Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectom-ized mice. Bone 2004;35:489-497.
5. Trivedi R, Kumar S, Kumar A, et al. Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats. Mol Cell Endocrinol 2008; 289:85-93.
6. Horcajada-Molteni MN, Crespy V, Coxam V, Davicco MJ, Remesy C, Barlet JP. Rutin inhibits ovariectomy-induced osteopenia in rats. J Bone Miner Res 2000;15:2251-2258.
7. Nassar AH, Abd Essamad HM, Awwad JT, Khoury NG, Usta IM. Gynecologists' attitudes towards hormone therapy in the post BWomen's Health Initiative[study era. Maturitas 2005;52:18-25.
8. Canderelli R, Leccesse LA, Miller NL, Unruh Davidson J. Benefits of hormone replacement therapy in postmenopausal women. J Am Acad Nurse Pract 2007;19:635-641.
9. Coxam V. New advances in osteoporosis nutritional prevention. Med Sci (Paris) 2005;21:297-301.
10. Gurib-Fakim A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol Aspects Med 2006;27:1-93.
11. Maurya R, Singh G, Yadav PP. Antiosteoporotic agents from natural sources. In: Rahman AU, ed. Studies in Natural Product Chemistry, Bioactive Natural Products. New York: Elsevier, 2008:517-548.
12. Gaur RD. Flora of District Garhwal, North West Himalaya. Srinagar, Garhwal, India: Trans Media, 1999:86.
13. Sharan K, Siddiqui JA, Swarnkar G, et al. Extract and fraction from Ulmus wallichiana Planchon promote peak bone achievement and have a nonestrogenic osteoprotective effect. Menopause 2010;17:393Y402.
14. Manach C, Williamson G, Morand C, Scalbert A, Remesy C. Bio-availability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005;81:230S-242S.
15. Sharan K, Siddiqui JA, Swarnkar G, Maurya R, Chattopadhyay N. Role of phytochemicals in the prevention of menopausal bone loss: evidence from in vitro and in vivo, human interventional and pharmacokinetic studies. Curr Med Chem 2009;16:1138-1157.
16. Rawat P, Kumar M, Sharan K, Chattopadhyay N, Maurya R. Ulmosides A and B: flavonoid 6-C-glycosides from Ulmus wallichiana, stimulating osteoblast differentiation assessed by alkaline phosphatase. Bioorg Med Chem Lett 2009;19:4684-4687.
17. Frost HM, Jee WS. On the rat model of human osteopenias and osteoporoses. Bone Miner 1992;18:227-236.
18. Kalu DN. The ovariectomized rat model of postmenopausal bone loss. Bone Miner 1991;15:175-191.
19. Trivedi R, Kumar A, Gupta V, et al. Effects of Egb 761 on bone mineral density, bone microstructure, and osteoblast function: possible roles of quercetin and kaempferol. Mol Cell Endocrinol 2009;302:86-91.
20. Bhargavan B, Gautam AK, Singh D, et al. Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling. J Cell Biochem 2009;108:388-399.
21. Hildebrand T, Ruegsegger P. Quantification of bone microarchitecture with the structure model index. Comput Methods Biomech Biomed Engin 1997;1:15-23.
22. Littlefield BA, Gurpide E, Markiewicz L, McKinley B, Hochberg RB. A simple and sensitive microtiter plate estrogen bioassay based on stimulation of alkaline phosphatase in Ishikawa cells: estrogenic action of delta 5 adrenal steroids. Endocrinology 1990;127:2757-2762.
23. Singh RP, Sabarinath S, Gautam N, Gupta RC, Singh SK. Liquid chromatographic tandem mass spectrometric assay for quantification of 97-78 and its metabolite 97-63: a promising trioxane antimalarial in monkey plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877:2074-2080.
24. Comelekoglu U, Bagis S, Yalin S, et al. Biomechanical evaluation in osteoporosis: ovariectomized rat model. Clin Rheumatol 2007;26:380-384.
25. Holinka CF, Hata H, Kuramoto H, Gurpide E. Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial cancer cells (Ishikawa line). Cancer Res 1986;46:2771-2774.
26. Liu J, Burdette JE, Xu H, et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 2001;49:2472-2479.
27. Horcajada MN, Habauzit V, Trzeciakiewicz A, et al. Hesperidin inhibits ovariectomized-induced osteopenia and shows differential effects on bone mass and strength in young and adult intact rats. J Appl Physiol 2008;104:648-654.
28. MacGregor JI, Jordan VC. Basic guide to the mechanisms of anti-estrogen action. Pharmacol Rev 1998;50:151-196.
29. Neves ECM. Association of ovarian and uterine cancers with postmeno-pausal hormonal treatments. Clin Obstet Gynecol 2008;51:607-617.
30. Scalbert A, Manach C, Morand C, Remesy C, Jimenez L. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 2005;45:287-306.
31. Stalmach A, Mullen W, Pecorari M, Serafini M, Crozier A. Bioavail-ability of C-linked dihydrochalcone and flavanone glucosides in humans following ingestion of unfermented and fermented rooibos teas. J Agric Food Chem 2009;57:7104-7111.
32. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008;22:659-661.